6CM
CLBTW

683 Capital Management’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

683 Capital Management’s Portfolio CLBTW Stock Details CLBTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-172,950
Closed -$134K – 254
2022
Q2 		$134K Sell
172,950
-363,293
-68% -$331K 0.01% 181
2022
Q1 		$681K Sell
536,243
-100,000
-16% -$126K 0.04% 182
2021
Q4 		$1.12M Sell
636,243
-229,897
-27% -$510K 0.04% 165
2021
Q3 		$1.86M Buy
+866,140
New +$1.99M 0.07% 119

Other funds holding CLBTW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $40.5M AUM 5.55% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.27B AUM 18.22% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

683 Capital Management's CLBTW Position: Q3 2022 in Review

683 Capital Management sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q3 2022, closing a stake of 172,950 shares — an estimated $134K sold.

683 Capital Management first reported a position in CLBTW in Q3 2021 and held it in 4 quarters. The position peaked at $1.86M in Q3 2021. 23 funds tracked by Wall St. Rank hold CLBTW as of Q3 2022.

  • 683 Capital Management reported no remaining Cellebrite DI Ltd. Warrants position as of Q3 2022 after selling out during the quarter.
  • 683 Capital Management sold 172,950 Cellebrite DI Ltd. Warrants shares in Q3 2022, an estimated $134K.
  • 683 Capital Management first reported a position in Cellebrite DI Ltd. Warrants in Q3 2021 and held it in 4 quarters.
  • 683 Capital Management's Cellebrite DI Ltd. Warrants position peaked at $1.86M in Q3 2021.
  • 23 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q3 2022.

Based on 683 Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.